| Pityriasis alba—common disease, enigmatic entity: up‐to‐date review of the literature N Miazek, I Michalek, M Pawlowska‐Kisiel, M Olszewska, L Rudnicka Pediatric dermatology 32 (6), 786-791, 2015 | 82 | 2015 |
| HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies M Bobrowicz, M Dwojak, B Pyrzynska, J Stachura, A Muchowicz, ... Blood, The Journal of the American Society of Hematology 130 (14), 1628-1638, 2017 | 50 | 2017 |
| B-cell receptor signaling in the pathogenesis of lymphoid malignancies K Bojarczuk, M Bobrowicz, M Dwojak, N Miazek, P Zapala, A Bunes, ... Blood Cells, Molecules, and Diseases 55 (3), 255-265, 2015 | 43 | 2015 |
| Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate A Graczyk-Jarzynka, A Goral, A Muchowicz, R Zagozdzon, M Winiarska, ... Redox biology 21, 101062, 2019 | 32 | 2019 |
| FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy B Pyrzynska, M Dwojak, A Zerrouqi, G Morlino, P Zapala, N Miazek, ... Oncoimmunology 7 (5), e1423183, 2018 | 31 | 2018 |
| Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies M Winiarska, K Bojarczuk, B Pyrzynska, J Bil, M Siernicka, M Dwojak, ... MAbs 6 (5), 1300-1313, 2014 | 21 | 2014 |
| Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern BA Dybowski, P Zapała, E Bres-Niewada, Ł Zapała, N Miązek-Zapała, ... BMC Infectious Diseases 18, 1-7, 2018 | 16 | 2018 |
| Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate P Zapala, B Dybowski, N Miazek, P Radziszewski International braz j urol 43, 209-215, 2017 | 15 | 2017 |
| Influence of left atrial size on the outcome of pulmonary vein isolation in patients with atrial fibrillation M Kiliszek, N Miązek, M Peller, S Gajda, E Koźluk, P Lodziński, ... Kardiologia Polska (Polish Heart Journal) 72 (11), 1135-1140, 2014 | 9 | 2014 |
| Selective inhibition of HDAC6 sensitizes cutaneous T‑cell lymphoma to PI3K inhibitors M Bobrowicz, A Slusarczyk, J Domagala, M Dwojak, D Ignatova, ... Oncology letters 20 (1), 533-540, 2020 | 7 | 2020 |
| The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era N Miazek-Zapala, A Slusarczyk, A Kusowska, P Zapala, M Kubacz, ... Cells 10 (6), 1511, 2021 | 4 | 2021 |
| A stone pushed back to the collecting system–long therapeutic path in centers with limited access to flexible instruments E Bres-Niewada, B Dybowski, P Zapała, S Poletajew, N Miązek-Zapała, ... Central European Journal of Urology 71 (2), 186, 2018 | 1 | 2018 |
| Inhibitors of Src family and AKT regulate the activity of CD20 promoter B Pyrzynska, K Bojarczuk, M Winiarska, J Bil, N Miazek, P Zapala, ... Blood 122 (21), 1838, 2013 | 1 | 2013 |
| Natural killer immune response is promoted by the treatment of B-cell lymphoma cancer cells with membrane ionophores. A Zerrouqi, A Torun, N Miazek, Z Pilch, J Golab, B Pyrzynska CANCER IMMUNOLOGY RESEARCH 8 (3), 92-93, 2020 | | 2020 |
| Abstract B14: Natural killer immune response is promoted by the treatment of B-cell lymphoma cancer cells with membrane ionophores A Zerrouqi, A Torun, N Miazek, Z Pilch, J Golab, B Pyrzynska Cancer Immunology Research 8 (3_Supplement), B14-B14, 2020 | | 2020 |
| Salinomycin expands the cytotoxicity of both anti-CD20 monoclonal antibodies and natural killer cells towards non-Hodgkin lymphomas A Zerrouqi, N Miazek-Zapala, A Torun, P Zapala, J Golab, M Winiarska, ... CANCER RESEARCH 79 (13), 2019 | | 2019 |
| Abstract LB-261: Salinomycin expands the cytotoxicity of both anti-CD20 monoclonal antibodies and natural killer cells towards non-Hodgkin lymphomas A Zerrouqi, N Miazek-Zapala, A Torun, P Zapala, J Golab, M Winiarska, ... Cancer Research 79 (13_Supplement), LB-261-LB-261, 2019 | | 2019 |
| Selective inhibition of HDAC6 sensitizes CTCL to PI3K inhibitors M Bobrowicz, J Stachura, M Dwojak, D Ignatova, YT Chang, C Iselin, ... European Journal of Cancer 119, S37, 2019 | | 2019 |
| Abstract B27: B-cell lymphoma response to anti-CD20 antibodies based therapies is tightly modulated by FOXO1-mediated MS4A1 gene transcription A Zerrouqi, B Pyrzynska, M Dwojak, N Miazek, P Zapala, J Golab, ... Cancer Immunology Research 6 (9_Supplement), B27-B27, 2018 | | 2018 |
| FOXO1 is transcriptional regulator of malignant B-cell surface antigen CD20, the target for therapeutic monoclonal antibodies B Pyrzynska, A Zerrouqi, M Dwojak, G Morlino, P Zapala, N Miazek, ... CANCER IMMUNOLOGY RESEARCH 6 (9), 2018 | | 2018 |
